Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
World Journal of Urology
Published September 11, 2026
Six-factor-based stratification system for enfortumab vedotin monotherapy in pre-treated patients...
September 13, 2026
Medspoke
Medspoke
Urology (the "Gold Journal")
Published September 12, 2026
00:00
--:--
Risk of subsequent recurrences and progression in NMIBC patients with early recurrence.
September 13, 2026
Share
Risk of subsequent recurrences and progression in NMIBC patients with early recurrence.
https://www.medspoke.co/channel_journal?id=689&tap_id=13860
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Urologic Oncology
Published September 12, 2026
Advancing clinical trials for rare renal cell carcinoma subtypes: Consensus statements from the I...
September 13, 2026
Why are you reporting this TALK?